XML 16 R6.htm IDEA: XBRL DOCUMENT v3.23.3
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Common Shares Outstanding
Common Stock
Additional Paid-In Capital
Retained Earnings
Accum. Other Comp. Gain (Loss)
Non- Controlling Interest
Beginning balance (in shares) at Dec. 31, 2021   27,714,071          
Beginning balance at Dec. 31, 2021 $ 558,267   $ 426,091 $ 98,073 $ 42,015 $ (7,960) $ 48
Increase (Decrease) in Shareholders' Equity              
Net income 19,438       19,438    
Other comprehensive income (loss) (79,387)         (79,387)  
Cash dividends declared (7,201)       (7,201)    
Common stock sold by directors' deferred compensation plan 1,114   1,114        
Shares of common stock repurchased and other related costs (in shares)   (234,981)          
Common stock repurchased and retired and other related costs (6,731)   (6,731)        
Share-based compensation (in shares)   105,839          
Share-based compensation 876   679 197      
Non-controlling interest 2           2
Ending balance (in shares) at Mar. 31, 2022   27,584,929          
Ending balance at Mar. 31, 2022 486,378   421,153 98,270 54,252 (87,347) 50
Beginning balance (in shares) at Dec. 31, 2021   27,714,071          
Beginning balance at Dec. 31, 2021 558,267   426,091 98,073 42,015 (7,960) 48
Increase (Decrease) in Shareholders' Equity              
Net income 53,747            
Other comprehensive income (loss) (141,293)         (141,293)  
Ending balance (in shares) at Sep. 30, 2022   27,262,879          
Ending balance at Sep. 30, 2022 438,468   412,994 100,426 74,301 (149,253) 0
Beginning balance (in shares) at Mar. 31, 2022   27,584,929          
Beginning balance at Mar. 31, 2022 486,378   421,153 98,270 54,252 (87,347) 50
Increase (Decrease) in Shareholders' Equity              
Net income 17,594       17,594    
Other comprehensive income (loss) (39,085)         (39,085)  
Cash dividends declared (7,153)       (7,153)    
Common stock sold by directors' deferred compensation plan 927   927        
Shares of common stock repurchased and other related costs (in shares)   (174,429)          
Common stock repurchased and retired and other related costs (4,218)   (4,218)        
Share-based compensation (in shares)   53,062          
Share-based compensation 707     707      
Non-controlling interest (50)           (50)
Ending balance (in shares) at Jun. 30, 2022   27,463,562          
Ending balance at Jun. 30, 2022 455,100   417,862 98,977 64,693 (126,432) 0
Increase (Decrease) in Shareholders' Equity              
Net income 16,715       16,715    
Other comprehensive income (loss) (22,821)         (22,821)  
Cash dividends declared (7,107)       (7,107)    
Shares of common stock repurchased and other related costs (in shares)   (218,000)          
Common stock repurchased and retired and other related costs (4,868)   (4,868)   0    
Share-based compensation (in shares)   17,317          
Share-based compensation 1,449   0 1,449      
Ending balance (in shares) at Sep. 30, 2022   27,262,879          
Ending balance at Sep. 30, 2022 $ 438,468   412,994 100,426 74,301 (149,253) $ 0
Beginning balance (in shares) at Dec. 31, 2022 27,025,070 27,025,070          
Beginning balance at Dec. 31, 2022 $ 452,871   408,071 101,346 87,438 (143,984)  
Increase (Decrease) in Shareholders' Equity              
Net income 16,187       16,187    
Other comprehensive income (loss) 11,256         11,256  
Cash dividends declared (7,025)       (7,025)    
Shares of common stock repurchased and other related costs (in shares)   (101,760)          
Common stock repurchased and retired and other related costs (2,205)   (2,205)        
Share-based compensation (in shares)   82,235          
Share-based compensation (158)     (158)      
Ending balance (in shares) at Mar. 31, 2023   27,005,545          
Ending balance at Mar. 31, 2023 $ 470,926   405,866 101,188 96,600 (132,728)  
Beginning balance (in shares) at Dec. 31, 2022 27,025,070 27,025,070          
Beginning balance at Dec. 31, 2022 $ 452,871   408,071 101,346 87,438 (143,984)  
Increase (Decrease) in Shareholders' Equity              
Net income 43,803            
Other comprehensive income (loss) $ (5,563)         (5,563)  
Ending balance (in shares) at Sep. 30, 2023 27,043,169 27,043,169          
Ending balance at Sep. 30, 2023 $ 468,598   405,439 102,550 110,156 (149,547)  
Beginning balance (in shares) at Mar. 31, 2023   27,005,545          
Beginning balance at Mar. 31, 2023 470,926   405,866 101,188 96,600 (132,728)  
Increase (Decrease) in Shareholders' Equity              
Net income 14,475       14,475    
Other comprehensive income (loss) (2,547)         (2,547)  
Cash dividends declared (7,029)       (7,029)    
Shares of common stock repurchased and other related costs (in shares)   (23,750)          
Common stock repurchased and retired and other related costs (355)   (355)        
Share-based compensation (in shares)   63,997          
Share-based compensation 809     809      
Ending balance (in shares) at Jun. 30, 2023   27,045,792          
Ending balance at Jun. 30, 2023 476,279   405,511 101,997 104,046 (135,275)  
Increase (Decrease) in Shareholders' Equity              
Net income 13,141       13,141    
Other comprehensive income (loss) (14,272)         (14,272)  
Cash dividends declared (7,031)       (7,031)    
Shares of common stock repurchased and other related costs (in shares)   (4,500)          
Common stock repurchased and retired and other related costs (72)   (72)        
Share-based compensation (in shares)   1,877          
Share-based compensation $ 553     553      
Ending balance (in shares) at Sep. 30, 2023 27,043,169 27,043,169          
Ending balance at Sep. 30, 2023 $ 468,598   $ 405,439 $ 102,550 $ 110,156 $ (149,547)